SAGENT PHARMA Trademark

Trademark Overview


On Thursday, August 16, 2007, a trademark application was filed for SAGENT PHARMA with the United States Patent and Trademark Office. The USPTO has given the SAGENT PHARMA trademark a serial number of 77256642. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 6, 2012. This trademark is owned by Sagent Holding Co.. The SAGENT PHARMA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals, namely, alkalizing agents, analgesics and anesthetics, antacids, anticholinergics, antihistamines, anti-infectives, anti-inflammatory agents, anticonvulsants, antidotes, antiemetics, antipsychotics, anxiolytics, blood modifiers, bronchodialators, cardiovasculars, diuretics, hormones, diluents, electrolytes, vitamins, oncolytics, immunosuppressive agents, transplantation agents, imaging agents, vascular targeting agents, and sensitizing agents for chemotherapy-resistant tumors; Pre-filled syringes sold filled with alkalizing agents; pre-filled syringes sold filled with analgesics; pre-filled syringes sold filled with anesthetics; pre-filled syringes sold filled with antacids; pre-filled syringes sold filled with anticholinergics; pre-filled syringes sold filled with antihistamines; pre-filled syringes sold filled with anti-infectives; pre-filled syringes sold filled with anti-inflammatory agents; pre-filled syringes sold filled with anticonvulsants; pre-filled syringes ...
sagent pharma

General Information


Serial Number77256642
Word MarkSAGENT PHARMA
Filing DateThursday, August 16, 2007
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 6, 2012
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 13, 2009

Trademark Statements


Disclaimer with Predetermined Text"PHARMA"
Goods and ServicesPharmaceuticals, namely, alkalizing agents, analgesics and anesthetics, antacids, anticholinergics, antihistamines, anti-infectives, anti-inflammatory agents, anticonvulsants, antidotes, antiemetics, antipsychotics, anxiolytics, blood modifiers, bronchodialators, cardiovasculars, diuretics, hormones, diluents, electrolytes, vitamins, oncolytics, immunosuppressive agents, transplantation agents, imaging agents, vascular targeting agents, and sensitizing agents for chemotherapy-resistant tumors; Pre-filled syringes sold filled with alkalizing agents; pre-filled syringes sold filled with analgesics; pre-filled syringes sold filled with anesthetics; pre-filled syringes sold filled with antacids; pre-filled syringes sold filled with anticholinergics; pre-filled syringes sold filled with antihistamines; pre-filled syringes sold filled with anti-infectives; pre-filled syringes sold filled with anti-inflammatory agents; pre-filled syringes sold filled with anticonvulsants; pre-filled syringes sold filled with antidotes; pre-filled syringes sold filled with antiemetics; pre-filled syringes sold filled with antipsychotics; pre-filled syringes sold filled with anxiolytics; pre-filled syringes sold filled with blood modifiers; pre-filled syringes sold filled with bronchodialators; pre-filled syringes sold filled with cardiovasculars; pre-filled syringes sold filled with diuretics; pre-filled syringes sold filled with hormones; pre-filled syringes sold filled with diluents; pre-filled syringes sold filled with electrolytes; pre-filled syringes sold filled with vitamins; pre-filled syringes sold filled with oncolytics; pre-filled syringes sold filled with immunosuppressive agents; pre-filled syringes sold filled with transplantation agents; pre-filled syringes sold filled with imaging agents; pre-filled syringes sold filled with vascular targeting agents; pre-filled syringes sold filled with sensitizing agents for chemotherapy-resistant tumors; Safety syringe devices sold filled with alkalizing agents; safety syringe devices sold filled with analgesics; safety syringe devices sold filled with anesthetics; safety syringe devices sold filled with antacids; safety syringe devices sold filled with anticholinergics; safety syringe devices sold filled with antihistamines; safety syringe devices sold filled with anti-infectives; safety syringe devices sold filled with anti-inflammatory agents; safety syringe devices sold filled with anticonvulsants; safety syringe devices sold filled with antidotes; safety syringe devices sold filled with antiemetics; safety syringe devices sold filled with antipsychotics; safety syringe devices sold filled with anxiolytics; safety syringe devices sold filled with blood modifiers; safety syringe devices sold filled with bronchodialators; safety syringe devices sold filled with cardiovasculars; safety syringe devices sold filled with diuretics; safety syringe devices sold filled with hormones; safety syringe devices sold filled with diluents; safety syringe devices sold filled with electrolytes; safety syringe devices sold filled with vitamins; safety syringe devices sold filled with oncolytics; safety syringe devices sold filled with immunosuppressive agents; safety syringe devices sold filled with transplantation agents; safety syringe devices sold filled with imaging agents; safety syringe devices sold filled with vascular targeting agents; safety syringe devices sold filled with sensitizing agents for chemotherapy-resistant tumors; Pharmaceuticals for treatment of cancer; pharmaceuticals to treat vascular diseases; Drug delivery systems sold as an integral component of drugs, namely, intradermal injection system for injection of anesthetics; Injectable drugs and therapeutic solutions for the treatment of cancer and vascular diseases; injectable drugs and therapeutic solutions for the treatment of psychotic disorders; injectable drugs and therapeutic solutions for the treatment of pain; injectable drugs and therapeutic solutions for the treatment of allergies; injectable drugs and therapeutic solutions for the treatment of infections; injectable drugs and therapeutic solutions for the treatment of cardiovascular disease; injectable drugs and therapeutic solutions for the treatment of kidney disease; injectable drugs and therapeutic solutions for the treatment of hormonal imbalances; injectable drugs and therapeutic solutions for the treatment of vitamin deficiencies; injectable drugs and therapeutic solutions for the treatment of electrolyte deficiencies; injectable drugs and therapeutic solutions for the treatment of heartburn; injectable drugs and therapeutic solutions for the treatment of anxiety; injectable drugs and therapeutic solutions for immunosuppression; injectable drugs and therapeutic solutions for imaging; injectable drugs and therapeutic solutions for the treatment of seizures; Injectable drugs and therapeutic solutions for the treatment of cancer and vascular diseases sold in kits comprising pre-filled IV bags with devices for intravenous administration, namely, transfer pins, vials, needles, and adaptors; injectable drugs and therapeutic solutions for the treatment of psychotic disorders sold in kits comprising pre-filled IV bags with devices for intravenous administration, namely, transfer pins, vials, needles, and adaptors; injectable drugs and therapeutic solutions for the treatment of pain sold in kits comprising pre-filled IV bags with devices for intravenous administration, namely, transfer pins, vials, needles, and adaptors; injectable drugs and therapeutic solutions for the treatment of allergies sold in kits comprising pre-filled IV bags with devices for intravenous administration, namely, transfer pins, vials, needles, and adaptors; injectable drugs and therapeutic solutions for the treatment of infections sold in kits comprising pre-filled IV bags with devices for intravenous administration, namely, transfer pins, vials, needles, and adaptors; injectable drugs and therapeutic solutions for the treatment of cardiovascular disease sold in kits comprising pre-filled IV bags with devices for intravenous administration, namely, transfer pins, vials, needles, and adaptors; injectable drugs and therapeutic solutions for the treatment of kidney disease sold in kits comprising pre-filled IV bags with devices for intravenous administration, namely, transfer pins, vials, needles, and adaptors; injectable drugs and therapeutic solutions for the treatment of hormonal imbalances sold in kits comprising pre-filled IV bags with devices for intravenous administration, namely, transfer pins, vials, needles, and adaptors; injectable drugs and therapeutic solutions for the treatment of vitamin deficiencies sold in kits comprising pre-filled IV bags with devices for intravenous administration, namely, transfer pins, vials, needles, and adaptors; injectable drugs and therapeutic solutions for the treatment of electrolyte deficiencies sold in kits comprising pre-filled IV bags with devices for intravenous administration, namely, transfer pins, vials, needles, and adaptors; injectable drugs and therapeutic solutions for the treatment of heartburn sold in kits comprising pre-filled IV bags with devices for intravenous administration, namely, transfer pins, vials, needles, and adaptors; injectable drugs and therapeutic solutions for the treatment of anxiety sold in kits comprising pre-filled IV bags with devices for intravenous administration, namely, transfer pins, vials, needles, and adaptors; injectable drugs and therapeutic solutions for immunosuppression sold in kits comprising pre-filled IV bags with devices for intravenous administration, namely, transfer pins, vials, needles, and adaptors; injectable drugs and therapeutic solutions for imaging sold in kits comprising pre-filled IV bags with devices for intravenous administration, namely, transfer pins, vials, needles, and adaptors; injectable drugs and therapeutic solutions for the treatment of seizures sold in kits comprising pre-filled IV bags with devices for intravenous administration, namely, transfer pins, vials, needles, and adaptors

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, August 20, 2007
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSAGENT PHARMACEUTICALS, INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressSCHAUMBURG, IL 60195

Party NameSagent Holding Co.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressGeorgetown
KY

Party NameSagent Holding Co.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGeorgetown
KY

Trademark Events


Event DateEvent Description
Monday, August 6, 2012ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, August 6, 2012ABANDONMENT - NO USE STATEMENT FILED
Thursday, January 5, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 4, 2012EXTENSION 4 GRANTED
Wednesday, December 28, 2011EXTENSION 4 FILED
Wednesday, December 28, 2011TEAS EXTENSION RECEIVED
Wednesday, October 5, 2011AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, July 6, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 5, 2011EXTENSION 3 GRANTED
Friday, July 1, 2011EXTENSION 3 FILED
Friday, July 1, 2011TEAS EXTENSION RECEIVED
Friday, January 28, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 27, 2011EXTENSION 2 GRANTED
Monday, January 3, 2011EXTENSION 2 FILED
Thursday, January 27, 2011CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, January 3, 2011TEAS EXTENSION RECEIVED
Wednesday, June 30, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 28, 2010EXTENSION 1 GRANTED
Monday, June 28, 2010EXTENSION 1 FILED
Monday, June 28, 2010TEAS EXTENSION RECEIVED
Tuesday, January 5, 2010NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 13, 2009OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 13, 2009PUBLISHED FOR OPPOSITION
Thursday, September 10, 2009LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, September 10, 2009APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, June 6, 2009REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Thursday, December 4, 2008REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Thursday, December 4, 2008ASSIGNED TO LIE
Tuesday, June 3, 2008NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, June 3, 2008LETTER OF SUSPENSION E-MAILED
Tuesday, June 3, 2008SUSPENSION LETTER WRITTEN
Tuesday, May 27, 2008TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, May 27, 2008CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, May 27, 2008TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, November 27, 2007NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, November 27, 2007NON-FINAL ACTION E-MAILED
Tuesday, November 27, 2007NON-FINAL ACTION WRITTEN
Monday, November 26, 2007ASSIGNED TO EXAMINER
Monday, August 20, 2007NEW APPLICATION ENTERED IN TRAM